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Abstract  
 
The translational efficiency of an in vitro transcribed (IVT) mRNA was measured upon delivery to 
primary skeletal muscle cells and to a mouse model system, towards the development of a predictive 
in vitro assay for the screening and validation of intramuscular mRNA-based vaccines. When IVT 
mRNA was delivered either naked or complexed with novel aminoglycoside-based delivery vehicles, 
significant differences in protein expression in vitro and in vivo were observed. We hypothesized that 
this previously anticipated discrepancy was due to differences in the mechanism of IVT mRNA 
endosomal entry and release following delivery. To address this, IVT mRNA was fluorescently labeled 
prior to delivery, to visualize its distribution. Colocalization with endosomal markers indicated that 
different entry pathways were utilized in vivo and in vitro, depending on the delivery vehicle, resulting 
in variations in protein expression levels. Since extracellular matrix stiffness (ECM) influences mRNA 
entry, trafficking and release, the effect of mechanotransduction on mRNA expression was 
investigated in vitro upon delivery of IVT mRNA alone, and complexed with delivery vehicles to 
skeletal muscle cells grown on ~10kPa hydrogels. This in vitro hydrogel model more accurately 
recapitulated the results obtained in vivo upon IM injection, indicating that this approach may assist in 
the characterization of mRNA based vaccines. 
 
 
Key Words: Skeletal Muscle cells; mRNA delivery; Hydrogels; ECM protein; Mechanotransduction; 
Nanoparticles. 
 
Abbreviated Title:  Mechanotransduction explains IVT mRNA expression differences in vitro and in vivo. 
 
1. Introduction 
 
    Since their early development, messenger RNA based vaccines have demonstrated their potential 
application in a wide variety of animal models as well as in humans [1,2,3]. For intra-muscular administration, a 
formulation that stabilizes the mRNA-based vaccine against RNAse-mediated degradation, while promoting 
efficient cellular uptake, is beneficial.  
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     Cationic lipid nanoparticles have been widely utilized for delivering nucleic acids, as they are rapidly 
internalized due to their surface charge as well as their ability to disrupt the endosomal membrane to facilitate 
cargo release in to the cytosol [4,5]. They have also been successfully utilized in topical gene delivery, due to 
their surface charge interaction with the skin [6]. Although cationic lipid particles are efficiently expressed in 
vitro, little success has been achieved in vivo [7,8]. On the contrary, naked synthetic in vitro transcribed (IVT) 
mRNA injected intramuscularly is expressed in vivo in mice but not in vitro [9,10]. These discrepancies 
between in vivo and in vitro transfection efficiencies are not surprising, since it has been previously reported in 
experiments performed with nucleic acids complexed with different delivery vehicles. The results of such 
experiments, summarized in Table 1, further complicate our understanding of the mechanisms underlying 
successful delivery of nucleic acids-based therapeutics. This highlights the importance of novel approaches 
that allow for high-throughput screening of nanocarriers in vitro toward the development of vaccine 
formulations, prior to in vivo studies.   
 
     IVT mRNA often enter cells by receptor-mediated endocytosis, followed by uptake into the endosomal 
system and degradation in lysosomes. However, a fraction of mRNAs escape from the endosomal 
compartment and are released into the cytosol, leading to ribonucleoprotein formation and protein expression 
[19]. The entry pathways for lipid and polymer-based complexes depend on the cell type, expression of specific 
endocytic markers and charge of the nanocomplexes. For example, muscle and endothelial cells, fibroblasts, 
and adipocytes express high amounts of caveolin, and therefore caveolin-mediated entry prevails [20,21]. 
Differences in entry pathways are also observed between different delivery vehicles. For example, lipoplexes 
are internalized by clathrin-mediated endocytosis, and are expressed efficiently, whereas polyplexes are 
internalized by caveolae or by both clathrin and caveolin-dependent endocytosis, which leads to decreased 
expression efficiency [22,23].  
      
     Recently, easily dispersible and porous antibiotics-conjugated nanoparticles have been utilized to produce 
formulations for treating lung infection [24]. Kanamycin, an aminoglycoside antibiotic, potentiates the 
antibacterial effect of gold nanoparticles [25], therefore, kanamycin-capped gold particles were produced 
through a simple, biofriendly reaction to yield stable and monodispersed particles. These lipidic aminoglycoside 
derivatives are known to deliver siRNA and yield efficient gene silencing [26] as well as other nucleic acids 
[27,28]. 
  
     Here, bio-inspired ionizable lipids, containing an aminoglycoside cationic head group Kanamycin and 
bearing a cholesterol moiety as the hydrophobic part were synthesized. The resulting molecules were termed 
CholK (Cholesterol-Kanamycin) and DosK (DioleylSuccinyl-Kanamycine). We utilized CholK and DosK as 
delivery vehicles to measure the efficiency of transfection of IVT mRNA in vitro and in vivo, in order to 
understand the mechanism underlying the experimental discrepancies previously described. 
 
      We hypothesized, first of all, that the differences in protein production in vivo and in vitro might depend on 
the endocytic pathway utilized for entry. Therefore, we investigated the endocytic pathway of naked IVT mRNA 
or complexed with aminoglycoside lipidic derivatives, CholK and DosK, their release from the endosomal 
system, and protein expression in vitro, in human skeletal muscle cells, and in vivo, in a mouse model.  
 
     IVT mRNA was fluorescently labeled, prior to delivery, with the single-molecule-sensitive probes MTRIPs 
(multiply-labeled tetravalent RNA imaging probes) to assess its cellular localization with respect to the 
endocytic compartment. The RNA imaging strategy, composition and delivery of MTRIPs to living cells (Fig. 
S1) has been comprehensively described in Santangelo et al [29,30]. Briefly, MTRIPs are fluorescently labeled 
tetravalent single RNA sensitive probes consisting of a neutravidin core and four biotinylated fluorescently 
labeled 2’OMe-RNA oligonucleotides for specific mRNA targeting. This chemistry ensures an optimal level of 
affinity to bind target mRNAs without inhibiting translation, without the toxicity observed for other chemical 
modifications and without triggering a cellular immune response. To date, MTRIPs have been successfully 
utilized to study endogenous and plasmid-derived mRNAs such as β-actin, c-myc and poly(A) transcripts, and 
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the interaction with regulatory proteins and RNA granules in fixed and living cells via both colocalization 
analysis and proximity ligation assays (PLA)  [31,32,33,34,35,36]. MTRIPs were also utilized to study the RSV 
genome, its organization in viral particles, its localization in infected cells and interactions with viral and host 
cells [37,38].  Recently, we applied this single RNA sensitive probes to visualize synthetic mRNA uptake in 
vitro and in ex vivo tissue sections, as well as to characterize the release kinetics from endocytic 
compartments, and mRNA-protein expression correlations [39]. 
 
     To directly measure translation efficiency, an IVT mRNA encoding for the firefly luciferase was used as a 
model system. Our results indicated that IVT mRNA transfected with DosK was endocytosed prevalently by a 
caveolin-dependent pathway and was expressed efficiently in vitro, but not in vivo. On the contrary, naked IVT 
mRNA or complexed with CholK was endocytosed predominantly via a clathrin-dependent pathway and was 
expressed in vivo, but not in vitro.  
     
     To develop an in vitro, high-throughput assay that would allow for the accurate prediction in vitro, of the 
outcome of in vivo experiments, we first investigated the role of two individual ECM proteins, fibronectin and 
collagen, which are among the most abundant and extensively characterized in the context of nucleic acids 
delivery in vitro. Specifically, fibronectin and collagen were previously utilized to study the uptake mechanism 
and transfection efficiencies of polyplexes in mesenchymal stem cells (MSCs), NIH/3T3 and PC12 cells, and 
compared to laminin, polylysine and BSA [40,41,42]. For example, gene transfer was shown to be enhanced in 
NIH/3T3 cells plated on fibronectin, whereas collagen IV improved transfection in PC12 cells [43,44]. Here, 
addition of an excess of either fibronectin or collagen led to a switch in the endosomal entry pathway from 
caveolin to clathrin- mediated endocytosis, without altering protein production upon delivery of either naked IVT 
mRNA or complexed with CholK. Therefore, this strategy failed to accurately recapitulate the results obtained 
in vivo, addressing the need for further investigation.   
 
     We hypothesized that the differences in protein production in vivo and in vitro might be a consequence of a 
variation in substrate stiffness, which exerts varied mechanical cues attributing to the observed in vivo and in 
vitro discrepancies. The mechanical properties of cellular microenvironment transmit biochemical cues that 
alter cellular functions including motility, adhesion, proliferation, migration, apoptosis, and differentiation 
[45,46,47,48]. Moreover, the mechanical cues generated by physical forces like tension, compression and 
shear stress, and alteration in the mechanical forces by ECM directly or indirectly regulate transcriptional 
regulation, contributing to pluripotency, self-renewal and differentiation in embryonic and stem cells [49]. For 
example, matrix stiffness influences mesenchymal stem cell differentiation [50], modulates gene uptake and  
regulates the dissociation of pDNA from the condensation agent and  eventually affects pDNA expression [51]. 
ECM protein crosslinking and stiffening leads to progression of tumors in breast cancer via integrin signaling 
[52]. The transfection efficiency of polyplexes is highly enhanced by matrix stiffness [53,54,55].  
 
       Studies on biomaterials in tissue engineering indicated that hydrogels have the ability to generate 
physiologically relevant biomaterial in vitro. For example, hydrogels have been used to culture human 
embryonic stem cells (hES) [56,57]. Moreover, hydrogels with tunable stiffness have been used to study the 
regulation of differentiation in liver stem cells and hepatocytes [58] and during osteogenic differentiation of 
human mesenchymal cells [50].  
 
      Here, we utilized polyacrylamide (PA) hydrogels with stiffness of ~10 kPa [59,60] as a model to mimic ECM 
stiffness in muscle and studied the differences in the uptake, endosomal entry, release and protein expression 
of naked IVT mRNA or complexed with aminoglycoside lipidic derivatives in skeletal muscle cells. This 
approach more accurately recapitulated evidence obtained in vivo upon IM injection. Our results indicated that 
cells cultured on hydrogel significantly overexpressed genes involved in mRNA translation, suggesting how 
mechanical forces applied to cells may influence the activation of mRNA translational pathways.  
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2. Materials and methods  
 
2.1. mRNA synthesis 
     In brief, linearized plasmid harboring the sequence of luciferase downstream of a T7 promoter was 
transcribed using T7 RNA polymerase (Thermo Scientific, Braunschweig, Germany). mRNA vectors contained 
a 5′ cap structure, 5′ UTR, open reading frame, 3′ UTR and polyA tail. They were sequence optimized and did 
not include chemically modified nucleotides [1]. The mRNA was produced by T7-polymerase-based in vitro 
run-off transcription.  IVT mRNAs were purified according to the same protocol by reversed-phase 
chromatography using a PLRP-S stationary phase and an acetonitrile gradient in a triethylammonium acetate 
buffer. A detailed protocol has been described elsewhere [61]. 
 
2.2. Zeta potential of mRNA / Kanamycin lipidic derivatives complex 
 
     IVT Luciferase mRNA was provided by CureVac AG (Tübingen, Germany) and the delivery vehicles were 
provided by In Cell Art (Nantes, France). CholK was used at mRNA:CholK charge ratio of 0.1 and DosK at a 
charge ratio of 5. The particle size and zeta potential of the nanoparticles was measured with a Zetasizer Nano 
ZS (Malvern Instruments). The nanoparticles were diluted in either PBS to measure size or in deionized water 
to measure the zeta potential.  
 
2.3. Cell Line and Transfections  
 
     Hela and A549 cell line (ATCC) were cultured in DMEM (Lonza) supplemented with 10 % FBS (Hyclone), 
and 100 U/mL penicillin and 100 µg/ml streptomycin (Life Technologies), for the characterization of IVT mRNA 
labeled with MTRIPS transfected with Lipofectamine 2000 (following the manufacturer’s protocol). Primary 
human skeletal muscle cells, HSkMSC, (PromoCell) were grown in HSkMSC growth media (PromoCell) 
supplemented with growth factors, penicillin and streptomycin. Cells were plated the day prior to transfections 
with MTRIPs labeled or unlabeled firefly luciferase IVT mRNA, either naked or complexed with the delivery 
vehicles. For growth and differentiation of human skeletal muscle cells, the cells were cultured in skeletal 
muscle cell growth medium until they reach approximately 60 – 80 % confluence and then the medium was 
replaced with skeletal muscle cell differentiation medium (PromoCell). Cells were cultured for 5-6 days and 
media replaced every 2-4 day. Myotubes were switched back to HSkMSC growth media and used for 
transfections. Sol8 (ATCC) mouse skeletal muscle cells were cultured in DMEM (Lonza) supplemented with 20 
% FBS, penicillin and streptomycin.  
mRNA and CholK solutions were prepared in Ringers Lactate, RiLa (Bio scientific) in separate tubes in 
a final volume of 50 µl for experiments in Labtek II and in 250 µl for experiments in 6 well plates. The mRNA 
and CholK solutions were then mixed and incubated for 15 min. Similarly, mRNA and DosK solutions were 
prepared separately in RiLa in a final volume of 25 µl for experiments in Labtek II (Nunc) and in 100 µl of RiLa 
for experiments in 6 well plates. 500 ng RNA were used to transfect cells in Labtek II (Nunc) while 8 µg were 
used to transfect cells plated on 25 mm cover glass (Fisher) in 6 well plates. Cells were washed with Ca/Mg 
free PBS. Naked mRNA or complexed with CholK in RiLa solution were added to the cells for 10 min, followed 
by addition of fresh media. mRNA complexed with DosK was instead added to cells in media. Media was 
replaced after 4 h for all conditions. Cells were fixed and stained for endosomal markers 1.5 h or 6 h post-
delivery or lysed for luciferase expression detection 24 h post-delivery. To study mRNA endocytic pathway and 
protein production in presence of ECM proteins, Labtek II were coated with Fibronectin (Sigma) at 100 µM and 
collagen (Stem Cell Technologies) at 100 µM overnight at 4o C, followed by incubation at 37o C overnight 
before mRNA transfection [40]. Cells were pre-incubated for 30 min in Chlorpromazine, a clathrin inhibitor (Alfa 
Aesar) at the concentration of 10 µg/ml and genestein, a caveolin inhibitor (TSZ Chem) at the concentration of 
100 µM. 
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2.4. Preparation of CholK and DosK.  
 
     The nanoparticles were prepared in five steps starting from Kanamycin A, according to the schematic 
described in S1 and the procedures described below adapted from Sainlos et al [62]. Kanamycin-Cbz-Teoc3 3: 
Kanamycin A (1.15 g, 2.38 mmol, 1 eq.) was dissolved in water (10 mL). Et3N (0.33 mL, 2.38 mmol, 1 eq.) and 
a solution of N-benzyloxycarbonyloxy-5-norbornene-2, 3-dicarboximide (744 mg, 2.38 mmol, 1 eq.) in DMF (15 
mL) were successively added and the mixture was stirred at room temperature (RT) for 24 h. A solution of 2-
(trimethylsilyl)ethyl-4-nitrophenylcarbonate (2.30 g, 9.76 mmol, 4.1 eq.) in DMF (20 mL) and more Et3N (1.36 
mL, 9.76 mmol, 4.1 eq.) were then added and the yellow solution was stirred at 55o C for 48 hours. The 
mixture was then concentrated and the residue taken up with EtOAc, before washing with NaOH 1M (3 times), 
water and brine. The organic fraction was dried over MgSO4 and concentrated in vacuo. The residue was 
purified by flash chromatography (DCM/MeOH) to afford the expected product (1.22 g, 49 %). 1H NMR (MeOD, 
25°C), 0.02-0.05 (m, 27H), 0.98-1.02 (m, 6H), 1.50- 1.53 (m, 1H),  2.04-2.08 (m, 1H), 3.19 (t, J=9.4 Hz, 1H), 
3.41-3.75 (m, 14H), 4.11-4.16 (m, 7H), 5.03-5.10 (m, 4H), 7.29-7.38 (m, 5H); MS (ESI+) 1074.5 [M+Na]+. 
Kanamycin-Teoc3 4: To a solution of Kanamycin-Cbz-Teoc3 (1.3 g, 1.23 mmol, 1 eq.) in degassed wet MeOH 
(containing 10 % of H2O, 50 mL) was added 10 % Pd/C (0.17 g, 0.1 eq.). 3 cycles of vacuum/N2 were applied, 
followed by 3 cycles of vacuum/H2. The mixture was stirred overnight, then filtered over a pad of cellite and 
washed with EtOH. The filtrate was concentrated in vacuo and the residue purified by flash chromatography 
(DCM/MeOH) to afford the expected free amine (0.671 g, 59 %). 1H NMR (MeOD, 25°C), 0.00-0.02 (m, 27H), 
0.93-0.95 (m, 6H), 1.46-1.52 (m, 1H), 1.98-2.07 (m, 1H), 2.59-2.64 (m, 1H), 2.92-2.96 (m, 1H), 3.04-3.09 (t, 
J=9.3 Hz, 1H) 3.32-3.57 (m, 4H), 3.60-3.69 (m, 9H), 4.03-4.13 (m, 7H), 5.01 (s, 2H), 5.12 (s, 1H); MS (ESI+) 
939.6 [M+Na]+. 
(Cholesteryloxy-3-carbonyl)]Kanamycin-Teoc3 5: Et3N (0.12 mL, (1.5 mL, 0.87 mmol, 1.2 eq.) and cholesteryl 
chloroformate (0.330 g, 0.73 mmol, 1 eq.) were added to a solution of Kanamycin-Teoc3 (0.670 g, 0.73 mmol, 
1 eq.) in THF (70 mL) and DMF (15 mL). The mixture was stirred at RT overnight, then concentrated in vacuo. 
The residue was purified by flash chromatography (DCM/MeOH) to afford the expected product (0.655 g, 67 
%). 1H NMR (MeOD, 25o C), 0.00-0.02 (m, 27H), 0.67 (s, 3H), 0.82-1.59 (m, 39H), 1.84-2.02 (m, 6H), 2.27-
2.29 (m, 2H), 3.07-3.09 (m, 1H), 3.33-3.39 (m, 6H), 3.53-3.69 (m, 9H), 3.86-3.89 (m, 1H), 4.02-4-11 (m, 6H), 
4.55 (s, 1H), 5.01-5.01 (m, 2H), 5.34 (s, 1H);  MS (ESI+) 1352.0 [M+Na]+. 
CholK: To a suspension of (Cholesteryloxy-3-carbonyl)]Kanamycin-Teoc3 (0.650 g, 0.49 mmol) in DCM (6 mL) 
was slowly added TFA (12 mL) at 0°C. The solution w as stirred at RT for 2 h and then concentrated. After 3 
consecutive additions of MeOH and subsequent evaporations, the residue was purified by flash 
chromatography (reverse phase, C18-Silica, H2O+0.05 %TFA/MeOH) and lyophilized to give CholK (0.370 g, 
61 %). 1H NMR (MeOD, 25° C), 0.72 (s, 3H), 0.87-63 (m, 34H) , 1.85-2.07 (m, 6H), 2.32-2.34 (m, 2H), 2.45-
2.55 (m, 1H), 3.17-3.19 (m, 1H), 3.35-3.88 (m, 15H), 4.30-4.50 (m, 1H), 5.10 (s, 1H), 5.26 (s, 1H), 5.38 (s, 1H). 
MS (ESI+) 919.4 [M+Na]+. 
DosK was prepared starting from Kanamycin-Teoc3 4  then linked to 4-(Dioleylamino)-4-oxobutanoic Acid to  
produce N,N Dioleyl-succinamide-Kanamycin-Teoc3 followed by Teoc deprotection and purification, according 
to procedures extensively described in [27,28,63]. 
 
2.5. Labeling of Luciferase IVT mRNA 
 
     The synthesis of fluorescently labelled MTRIPs been previously described [29]. Briefly, MTRIPs consist of 
15-17 nucleotide long 2’ O-methyl RNA-DNA chimeric oligonucleotides, containing three to four amino-
modified thymidines, a short poly(T) linker and a 5’ biotin (Biosearch Technologies, Petaluma, CA).  
     Three oligonucleotides were selected for IVT mRNA labeling, complementary to 3 separate sequences in 
the human Albumin 3’ UTR of the reporter Luciferase mRNA (Table 2). Oligonucleotides were labeled with 
either Cy3B-NHS ester (GE Healthcare) or Dylight 650/680-NHS esters (Pierce) using manufacturer protocols, 
and excess dye was removed using 3 kDa centrifugal filters (Millipore). MTRIPs were assembled by incubation 
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of the biotinylated and fluorescently labeled oligos with Neutravidin (Pierce) at a 5:1 ratio for 1 hour at RT 
followed by filtration using 30kD MWCO centrifugal filters.  
     For labeling with MTRIPs, IVT mRNA was buffer exchanged in 1x PBS, heated to 75o C for 10 min and 
immediately placed on ice. MTRIPs were added at a 1:1 mRNA: MTRIP ratio, and incubation was allowed to 
proceed overnight at 37° C. The next day, the label ed IVT mRNA was filtered using a 200 kD MWCO 
ultrafiltration unit (Advantec MFS Inc) to remove unbound MTRIPs and concentrated by 30 kD MWCO 
centrifugal filters [39,64]  
 
2.6. Animals and Histology 
 
     Female BALB/C mice (Charles River, Wilmington, MA), age group 6 to 8 weeks were anesthetized with 
2.5% isoflurane. Mice were injected in the anterior tibialis, intramuscularly using 10 µg of IVT mRNA alone or 
complexed with CholK or DosK in 40 µl of RiLa using a 29G needle. The alternate leg was used as a sham 
injection control. Unlabeled or Dylight 680 -labeled IVT mRNA were used for luciferase mRNA expression 
studies, while IVT mRNA labeled with Cy3B was used to study the colocalization with endosomal markers. The 
anterior tibialis muscle was removed 1.5 h and 6 h post-delivery for endosomal marker staining and 16 hours 
post-delivery for luciferase protein expression. Tissue was fixed in 4% PFA, embedded in paraffin wax and 5-
micron thick sections were obtained. Mice were housed and manipulated under specific-pathogen-free 
conditions in the animal care facilities of Georgia Institute of Technology. All animal handling and experiments 
were performed in accordance with protocols approved by the IACUC at Georgia Institute of Technology. 
2.7. Luciferase Assay  
 
     Luciferase reporter expression was detected with the Bright glowTM Luciferase Assay System (Promega) for 
all in vitro studies. Cells (30,000) were grown in Labtek II, transfected with RNA alone or complexed with the 
delivery vehicles. 24 h post-delivery, cells were washed once with PBS, lysed with glo lysis buffer, and 100 µl 
of luciferin substrate reagent were added, according to the manufacturer protocol. Luminescence was 
measured immediately in a 96 well plate reader (Biotek Synergy H4 multimode plate reader). For hydrogel 
experiments, cells (0.5 X 106) were plated in a 6 well plate, transfected with IVT mRNA alone or with the 
delivery vehicles. 24 h post-delivery, cells were trypsinized, washed with PBS, lysed with Glo lysis buffer and 
the bright glow substrate reagent was added. The protein concentration of the lysates was quantified with BCA 
assay and the luciferase reads were normalized per mg of total protein.  
 
2.8. Immunofluorescence staining and microscopy analysis 
 
     Cells were fixed with 4 % PFA for 10 min, blocked with 5 % donkey serum and 1 % BSA, and 
immunostained using appropriate antibodies. The markers for the entry pathway utilized were Caveolin-1, and 
Clathrin Light Chain (Santa Cruz Biotechnology). The endocytic markers used were CD63 (mouse anti-CD63, 
Developmental studies Hybridoma Bank- DSHB), EEA1 (mouse anti-EEA1, BD Biosciences), and Rab7 (rabbit 
anti-Rab7, Abcam). Mouse tissue slides were stained with CD63 (Mouse anti-CD63, Santa Cruz 
Biotechnology), Rab5 and Rab7 (Rabbit anti-Rab5 and Rab7, Abcam). Luciferase protein was detected with a 
mouse anti-luciferase antibody (Santa Cruz Biotechnology). Secondary antibodies were purchased pre-
conjugated to either Alexa Fluor 488 (Life Technologies), Cy3 (Jackson Immunoresearch), or Alexa Fluor 647 
(Life Technologies). Secondary antibody incubation was performed for 45 min at 37o C for cell lines and at RT 
for tissue sections. Cells were also stained with DAPI for 5 minutes and mounted on glass slides with Prolong 
gold.   
     Cells and tissue sections were imaged with a Zeiss Plan-Apo 60X 1.4 NA oil objective on an Ultra View 
Spinning Disk equipped with a Hamamatsu Flash 4.0v2 CMOS camera or with a Nikon Plan-Apo 60X 1.4 NA 
oil objective on a Nikon Eclipse TE2000 widefield microscope equipped with a Hamamatsu C9000-02 EM-CCD 
camera.  Both microscopes were controlled by Volocity acquisition software (PerkinElmer). Where indicated, 
tissue sections were imaged with at Zeiss Plan-Apo 60X 1.4 NA oil objective on Zeiss Elyra PS.1/ 780 super 
resolution microscope.  
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Colocalization of IVT mRNA with endosomal markers was quantified using the Mander’s correlation 
coefficient for 15 cells per condition using Volocity software. The quantification of the percentage of cytosolic 
free mRNA and trapped in the endosomal system was performed using Volocity software as follows.  All 
mRNAs were identified as “objects”, sorted based on their size (either <1 µm or > 1 µm) and fluorescence 
intensity (above background), and colocalization with endocytic markers was measured.  mRNA granules with 
size > 1 µm either colocalized with endocytic markers or were found outside the cells, as verified by visual 
inspection. mRNA granules <1 µm were considered to be cytosolic if they did not overlap or touch endosomal 
markers. For each cell, the sum of cytosolic free mRNA and mRNA trapped in endosomes was recorded and 
plotted using Sigmaplot. At least 15 cells were used per condition in all experiments.  
 
2.9. Immunohistochemical Staining  
 
     Tissue section slides were deparaffinized and incubated in antigen retrieval buffer (Dako, Carpinteria, CA) 
for 20 min on steam followed by cooling at RT for 20 min. The slides were washed with TBS with 0.1 % tween-
20 (CalBioChem), with TBST for 5 min twice and blocked with TBST containing 5 % donkey serum and 1 % 
BSA for 1 h, and finally incubated with luciferase antibody (Goat anti-luciferase, Promega) overnight at 4o C. 
Next, the slides were washed three times with TBST and incubated with 3 % Hydrogen peroxide in PBS for 15 
min to quench the endogenous peroxidase activity. The slides were washed three times with PBST, incubated 
with HRP conjugated donkey anti-goat (Jackson Immunoresearch) for 45 min at room temperature, followed by 
secondary antibody incubation. The slides were washed with TBST three times and incubated in DAB 
chromogen and peroxidase substrate (Santacruz Biotechnology) for 10-15 min. The slides were the washed in 
DI water 2-3 times and counterstained with Hematoxylin for 30 secs – 1 min. Finally, the slides were washed in 
DI water, dehydrated with ethanol and xylene and mounted with Prolong. Fluorescent and bright field images 
were obtained with a Nikon Plan-Apochromat 40X objective on Nikon Eclipse TE2000 widefield microscope 
equipped with a Hamamatsu C9000-02 EM-CCD camera. Bright field imaging to visualize DAB staining was 
performed using spot imaging software. To quantify protein expression, images were color deconvolved using 
the H DAB function in Fiji Image J software. The Optical density (OD) of the DAB channel was then measured 
on a per image basis. 
 
2.10. Flow Cytometry 
 
     Cells were detached from the glass surface using warm Versene-EDTA (Lonza) for 5 min followed by 
fixation with 4 % paraformaldehyde for 10 min at 4° C. Cells were washed multiple times and resuspended in 
FACS buffer (Dulbecco’s Phosphate Buffered Saline -Ca2+-Mg2+ supplemented with 1 % FBS and 5 mM 
EDTA). IVT mRNA labeled with Dylight-650 was used for flow cytometry experiments. Experiments were 
performed using a BD FACS-Canto II flow cytometer and the data were analyzed using the FlowJo software. 
 
2.11. Synthesis of PA Hydrogel formulation functionalized with fibronectin or collagen 
 
     Cover glass (25 mm or 12 mm) were cleaned with plasma cleaner for 2.5 min and the glass surface was 
treated with APTES (VWR) for 5 min. The glass coverslips were washed in DI water 2-3 times, soaked in 
glutaraldehyde (Electron microcopy Solution, EMS) for 30 min at RT in a fume hood, washed once with DI 
water, dried and stored in a dessicator until used. PA hydrogels (1, 10 and 100 kPa) were prepared by mixing 
40 % acrylamide and 2 % bis –acrylamide solution (Biorad) followed by addition of APS and TEMED (VWR) for 
gel polymerization [65,66]. A droplet of gel was placed on a cover glass which was flipped over a glass slide to 
form a gel “sandwich”. Gels were polymerized for 30 min, washed with PBS 2-3 times and stored at 4o C in 
PBS no longer than 7 days. On the day of cell seeding, gels were washed with 50mM HEPES (pH-8.5) for 2-3 
times and incubated with 0.2 mg/ml Sulfo-SANPAH (Fisher Scientific). After Sulfo-SANPAH treatment, gels 
were immediately placed under 365 nm UV light source at a distance of approximately 3 inches and exposed 
for 10 min. Gels were washed with HEPES for 2-3 times and incubated with 20 µg/ml of fibronectin for 
minimum 3 h at 37o C. Gels were finally washed with PBS twice and used as a substrate for cell plating. 
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2.12. RNA Sequencing of skeletal muscle cells on glass and Hydrogels 
 
     Total RNA was extracted from HskMSc cells grown either on 25 mm coverglass or on hydrogels using 
Qaigen RNAeasy kit. RNA concentration was measured using a nanodrop and the quality was tested on a 
Bioanalyser. 100 -200 ng of RNA resuspended in nuclease free water was used for sequencing. Samples were 
analyzed at the Integrated Genomic Core facility at the Yerkes Center at Emory University. RNAseq results 
obtained in Fastq format were converted to BAM files using the Galaxy software. The BAM files were run 
through the Cuffdiff software for differential transgene expression. The volcano plot for all genes was obtained, 
indicating the significantly expressed genes in cells plated on glass versus hydrogels.  The final data were 
sorted for most significant differences in gene expression and run through Gene Set Enrichment Analysis 
(GSEA) which is a robust technique for analyzing gene expression data [67]. The software calculated an 
enrichment score (ES) reflecting the degree to which a set of genes is overrepresented at the extremes (top or 
bottom) of the entire ranked list L. The score is calculated by walking down the list L and the magnitude of the 
increment depends on the correlation of the gene with the phenotype.  Multiple hypothesis testing was done by 
the software which yields normalized enrichment score (NES) controlling the proportion of false positives by 
calculating the false discovery rate (FDR). The FDR is the estimated probability that a set with a given NES 
represents a false positive finding. 
 
2.13. Fluorescence in situ hybridization (FISH)  
 
     A549 cells (ATCC) were cultured in DMEM (Lonza) supplemented with 10 % FBS (Hyclone), 100 U/mL 
penicillin, and 100 µg/ml streptomycin (Life Technologies) and were plated on glass coverslips one day prior to 
transfection. Cells were transfected with 200 ng Dylight 650 pre-labeled IVT mRNA using Viromer RED 
(Lypocalyx), following the manufacturer protocol. Cells were fixed 6h post transfection using 70 % ethanol 
over-night at 4o C. FISH was performed using 5 nM Quazar 570 Stellaris RNA probes (Biosearch Technology) 
complementary to the transcript coding region following the manufacturer protocol. Hybridization was 
performed overnight at 37o C in a humid chamber. Female BALB/C mice were injected in the anterior tibialis, 
intramuscularly using 10 µg of cy3b labeled IVT mRNA complexed with Viromer RED in 40 µl of RiLa. The 
anterior tibialis muscle was removed 2 h post-delivery. Tissue was fixed in 4 % PFA overnight, followed by 30 
% sucrose incubation overnight. Tissue was OTC embedded, snap frozen in dry ice chilled isopentane and 
stored at -80o  C. Sections 10 um in thickness were used for FISH following the manufacturer protocol. Tissue 
sections were permeabilized in 50 % methanol: 50 % acetone for 10 min at -20o C. Hybridization was 
performed using 20 nM Quazar 670 Stellaris RNA probes complementary to the transcript coding region 
overnight at 37o C in a humid chamber. Samples were stained with DAPI and mounted using Prolong gold. 
Samples were imaged as previously described. 
 
2.14. Statistical Analysis 
 
     The data for luciferase assay, quantification of colocalization and quantification of the percentage of free 
/trapped mRNA were analyzed with Microsoft Excel and Sigmaplot. The statistically significant differences 
were tested with one-way and two-way ANOVA at p=0.05 followed by Holm-Sidak method for multiple 
comparison testing. All the luciferase assay experiments were performed three times in triplicates. 
Immunoflourescence experiments in vitro were performed three times in duplicates. Each animal experiment 
was performed on four mice. In RNAseq experiments, the nominal p value of the ES was calculated by the 
GSEA software by using an empirical phenotype-based permutation test procedure that preserves the complex 
correlation structure of the gene expression. The permutation of class labels provides a more biologically 
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reasonable assessment of significance than would be obtained when an entire database of gene sets is 
evaluated [67]. 
 
 
 
 
3. Results 
 
3.1. Synthesis of CholK and DosK   
      
     To prepare CholK, the primary amine on the 6’ position of Kanamycin A Sulfate 1 was selectively protected 
by a carboxybenzoyl (Cbz) group using N-benzyloxycarbonyloxy-5-norbornene-2,3-dicarboximide. The three 
remaining amino groups were then treated with 4-nitrophenyl 2-(trimethylsilyl)ethyl carbonate to yield a fully 
protected compound #3. Then, the Cbz group was removed by a classical hydrogenation reaction on 
supported Pd/C, giving the free aminomethyl derivative #4. The coupling of cholesteryl chloroformate with 
compound #4 led to the formation of the conjugate #5. Finally, CholK was obtained by deprotection of the Teoc 
groups using trifluoroacetic acid.  
      To prepare DosK reported in [21] the same procedure was followed as that of CholK except that the 
coupling of compound #4 with Cholesteryl Chloroformate was replaced by N-Succinyl-dioleylamine according 
to procedure extensively described in [27,28,63]. 
 
3.2. IVT mRNA expression in vivo and in vitro. 
 
     The firefly luciferase encoding IVT mRNA was labelled with three MTRIPs complementary to three 
sequences within the 3’ UTR in order to visualize its distribution in cells in culture and mouse muscle. Cells and 
tissue were fixed 6h and 2h post-delivery, respectively. To verify that MTRIPs remain bound to mRNA upon 
delivery (modified PEI was used for the in vitro experiments, and IM injection in vivo), samples were 
subsequently hybridized over-night, post-fixation, with Stellaris RNA FISH probes specific for the coding 
region. MTRIPs colocalized extensively with the FISH probes signal (Fig. S1), while no fluorescence was 
observed in mock transfected cells.  To further characterize the nanoparticles, the Zeta potential and mean 
particle size were measured. The Zeta potential of the mRNA complexed with CholK was -15.333 and 
complexed with DosK was 41.0333. The mean particle size of the mRNA plus CholK was 324 nm and mRNA 
plus DosK was 943 nm.  
The labeled IVT mRNA either naked or complexed with nanocarriers was then used to study the protein 
expression in vitro and in vivo. In vitro, when delivered to HSkMSC cells, mRNA complexed with DosK led to 
efficient mRNA expression, while no protein production was observed with naked mRNA or mRNA complexed 
with CholK (Fig. 1A and B) at the single cell level by immunostaining (Fig. 1A) and via luciferase assay (Fig. 
1B). Similar results were obtained in luciferase assays performed in myotubes (Fig. S8C) and Sol8 cells (Fig. 
S9C) delivered with mRNA naked, or complexed with nanoparticles. On the contrary, when injected 
intramuscularly in mice, naked mRNA or complexed with CholK yielded efficient luciferase expression by 
immunohistochemical staining, while no protein expression was detected with mRNA complexed with DosK 
(Fig. 1C and D). Interestingly, mRNA labeled with MTRIPs was clearly visible in tissues obtained from mice 
injected with naked mRNA or complexed with CholK, but not with DosK, indicating that nanocarriers affect 
mRNA entry, delivery and translatability in different fashions in vivo and in vitro. mRNA labelling with MTRIPs 
did not affect luciferase protein expression in HeLa cells (Fig. S2). The discrepancy between the observed 
efficiency of mRNA delivery and expression in vivo and in vitro, readily observable in our results, is a major 
concern for mRNA vaccine development. 
 
3.3. Endosomal entry pathway differs in vitro and in vivo. 
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     To further investigate the discrepancy between the results obtained in vivo and in vitro, the mRNA entry 
pathway was characterized upon delivery to HSkMSC cells and in mouse tissue, upon i.m. injection. IVT 
mRNA was fluorescently labeled with MTRIPs to observe its localization with respect to different endosomal 
components, such as clathrin (clathrin-light chain) and caveolin. In vitro, mRNA delivered alone or complexed 
with DosK and CholK colocalized prevalently with caveolin, indicating that mRNA enters HSkMSC cells via a 
caveolin-mediated pathway (Fig. 2A). Similar results were observed for entry pathway in differentiated skeletal 
muscle cells, myotubes (Fig. S8A) and mouse muscle cell line, Sol8 (Fig. S9A).  In vivo, mRNA delivered alone 
or complexed with CholK colocalized with clathrin, while mRNA complexed with DosK was mainly found 
outside the muscle tissue. Rare mRNA molecules delivered with DosK could be found within tissues but they 
did not colocalize with either clathrin or caveolin (Fig. 2B). The Mander’s overlap coefficient used to quantify 
the colocalization between mRNA and different endosomal markers, confirmed our observations (Fig. 2C-D, 
Fig. S8B and S9B).  
 
3.4. IVT mRNA release from endosomes in vitro and in vivo. 
     Caveolin and clathrin mediated endocytosis leads to exogenous mRNA trafficking to late endosomes and 
either degradation in the lysosomes or release in the cytosol. The fraction of mRNA trapped in endosomes or 
released can be determined by quantifying the colocalization of fluorescently labeled mRNA with early to mid-
endosomal markers EEA1 and Rab5, and the late endosomal markers CD63 and Rab7 [68,69], upon 
immunostaining. 
     In HSkMSC cells, IVT mRNA delivered alone or complexed with CholK colocalized with endosomal markers 
at 6 h, indicating that it remained trapped in the endosomal compartment. IVT mRNA complexed with DosK 
were mostly free in the cell cytoplasm, demonstrating cytosolic release. The quantification of the percentage of 
free and trapped mRNA, confirmed that free mRNA was significantly higher in vitro for IVT mRNA complexed 
with DosK and lower for mRNA alone or complexed with CholK. On the contrary, in vivo, the percentage of free 
mRNA was significantly higher when mRNA was injected alone or complexed with CholK (Fig. 3A and B). 
Representative images of the experiments are shown in Fig. S3. Overall, the efficiency of mRNA release 
correlated with the efficiency of luciferase expression shown in Fig. 1, both in vivo and in vitro. Mander’s 
overlap coefficient obtained from the colocalization analysis of mRNA and late endosomal markers both in vitro 
and in vivo showed similar trend for endosomal trapped mRNA (Fig. 3C).  
      To further characterize mRNA release from endosomal vesicles, we repeated the experiment in HSkMSC 
cells and performed immunostaining 1.5 h hours post-delivery. IVT mRNAs alone, complexed with DosK or 
CholK colocalized with all endosomal markers, indicating that, at this early time point, all mRNA is mainly 
trapped in endosomal vesicles (Fig. S4), independent of the delivery vehicle. Similar results were obtained in 
vivo, when mRNA alone or complexed with CholK was injected i.m. As previously observed, mRNA complexed 
with DosK was instead observed outside the muscle tissue (Fig. S5). 
   
3.5. Effect of ECM proteins on endosomal entry pathway, release and protein production 
 
     The data shown so far clearly highlight differences in the mechanisms of IVT mRNA endocytosis/trafficking 
in vitro and in vivo, dependent on the delivery vehicle, and, as a consequence, differences in protein 
expression efficiency. The extracellular matrix proteins play an important role in enhanced protein production of 
transfected plasmid [42]. We hypothesized that the observed protein production in vivo could be due to 
presence of abundant ECM proteins in muscle tissue.  Therefore, HSkMSC cells were plated on fibronectin or 
collagen, to determine if this would affect the IVT mRNA endosomal entry pathway, causing enhanced mRNA 
release in the cell cytosol and boost in protein production.  
     Fluorescently labeled IVT mRNA transfected alone, complexed with CholK and DosK were delivered to 
HSkMC cells and immunostaining for the endosomal components was performed as previously described. 
Colocalization analysis revealed a switch in the entry pathway from caveolin to clathrin-coated vesicles (Fig. 
S6) and endosomal release (Fig. S7). This observation was supported by the quantification of the Mander’s 
overlap coefficient (Fig. 4A). 
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     The quantification of the percentage of free and endosome-trapped mRNA revealed that, despite switching 
the entry pathway, both naked mRNA and complexed with CholK were not efficiently released in the cell 
cytoplasm 6h post-delivery. Interestingly, mRNA complexed with DosK was released more efficiently in the 
cytoplasm of cells plated on fibronectin than on collagen (Fig. 4B and C). As expected, mRNA transfected 
alone or with CholK were not expressed efficiently (Fig. 4D), as previously observed using cells plated on an 
uncoated surface (Fig. 1A). Interestingly, mRNA complexed with DosK was expressed more efficiently in cells 
plated on uncoated or fibronectin-coated surfaces, but yielded significantly lower protein expression in cells 
plated on collagen-coated surfaces (Fig. 4D). In summary, these results indicate that the presence of 
fibronectin induced a switch of the entry mechanism from caveolin to clathrin-mediated pathway but, overall, 
did not alter the expression efficiency of the delivered mRNA in vitro, suggesting that the presence of ECM 
proteins is not sufficient to mimic the in vivo microenvironment. 
 
3.6. Protein expression, IVT mRNA endosomal entry and release of muscle cells on Hydrogels 
 
     Next, we investigated how the extracellular matrix stiffness influences mRNA entry/trafficking/release and, 
as a consequence, protein synthesis. PA hydrogels functionalized with 20 µg/ml fibronectin and with a stiffness 
of 10 kPa were utilized as substrate to grow HSkMSC muscle cells [65], with the hypothesis that this would 
mimic the results obtained in our in vivo model. mRNA entry pathway, mRNA release and protein production 
on hydrogels were studied and compared to the results obtained using cells plated on an untreated glass 
surface. Skeletal muscle cells were cultured on hydrogels of varying stiffness (1, 10 and 100 kPa) and glass ( > 
10 GPa)  and were transfected with IVT mRNA complexed with CholK. Luciferase expression, measured at 24 
h, was significantly higher in cells cultured on 10 kPa hydrogels compared to 1 and 100 kPa (Fig. S10); this 
result confirms that mRNA translation depends on the stiffness of the substrate and that 10 kPa was the 
optimal stiffness for culturing HSkMSC cells for subsequent experiments.   
    The luciferase reporter activity measured 24h post-delivery in cells transfected with IVT mRNA alone or with 
CholK plated on hydrogels was significantly higher than that observed for cells plated on glass, while it 
decreased using mRNA complexed with DosK (Fig. 5A). Immunostaining for the endosomal entry markers 
caveolin and clathrin (Fig. 5C) and quantification of the colocalization between fluorescently labeled mRNA and 
caveolin or clathrin by Mander’s overlap coefficient (Fig. 5E) revealed that mRNA uptake was prevalently 
clathrin-mediated. 
     This was confirmed by treating cells plated on hydrogels with drugs that selectively inhibit either clathrin or 
caveolin-mediated vesicle formation. As expected, mRNA expression decreased significantly in cells 
preincubated in media containing the clathrin inhibitor “chlorpromazine”, while remained unchanged in cells 
preincubated in media containing the caveolin inhibitor “genestein” (Fig. 5B).  
     We quantified mRNA release from the endosomal system 6h post-delivery by immunostaining with mid to 
late endosomal markers in cells plated on hydrogels. The results showed that mRNA delivered alone or with 
CholK were readily released in the cell cytosol, whereas less endosomal release was observed with DosK (Fig. 
5D and F). Thus, when mRNA was delivered naked or complexed with CholK, protein expression was efficient. 
Interestingly, when mRNA was delivered with Dosk, the luciferase activity was not completely abrogated, as 
observed in vivo, but it was significantly reduced. 
 
3.7. Factors associated with efficient translation of IVT mRNA on softer substrate Hydrogels 
 
     Next, HSkMSC muscle cells on glass or hydrogel were transfected with labeled IVT mRNA either naked or 
complexed with CholK and mRNA uptake was measured using flow cytometry. mRNA uptake occurred more 
efficiently in cells plated on hydrogels (10 kPa stiffness) than on untreated glass coverslip (Fig. 6A) minimizing 
the differences between in vitro and in vivo results [53]. Cytoskeletal integrity, gene regulation and cell 
morphology are deeply influenced by substrate stiffness [70]. Since some transcriptional cofactors and ECM 
related genes are upregulated on softer substrates [71], RNAseq was performed on cells plated on hydrogels 
or on glass coverslips to identify which genes were upregulated. GSEA analysis showed a significant 
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overexpression of genes involved in Kegg ribosome, translation, metabolism of translation and 3’ UTR-
mediated translational regulation pathways with p value of 0 (Table 3). 
    The main genes enriched in the translational pathways are listed in Table 4. The data is also represented as 
a volcano plot indicating the significantly overexpressed genes in cells plated on hydrogels compared to glass 
coverslips (Fig. 6B). Interestingly, significant upregulation was found for several translational initiation factors 
including EIF2S3, EIF4H, EIF4A1, EIF3Dand EIF4G1, endosomal clathrin (CLTA), the ECM protein collagen 
(COL1A1, COL1A2) and ribosomal genes including RPL26, RPL27, RPL29, and RPS3A. 
 
 
 
4. Discussion 
 
     Characterizing the formulation of IVT mRNA complexed with nanocarriers in vitro is vital for the 
development of mRNA-based vaccines, but such screening has limitations due to the differences in protein 
expression observed in vitro (plated on glass or plastic) and in vivo. The data described in Table 1 clearly 
indicate that results of experiments in vitro frequently cannot be used to infer or predict the outcome of 
experiments in vivo, independently on the nanocarrier utilized for the delivery. The results presented here, 
obtained using both naked IVT mRNA and complexed with two delivery vehicles, CholK and DosK are 
summarized in Table 5, are consistent with this conclusion.  
 
     The endocytic pathway and subsequent release into the cytosol are closely related to mRNA intracellular 
fate and, therefore, to protein expression [72,73]. We observed that clathrin-mediated endocytosis led to high 
protein expression, in vivo, while caveolin-mediated endocytosis resulted in poor protein expression in vitro, for 
IVT mRNA delivered with CholK. On the contrary, IVT mRNA delivered with DosK entered through the caveolin 
pathway and expressed efficiently in vitro, but failed in vivo, highlighting the differences in endocytic pathway 
and protein expression in vitro and in vivo (Fig. 1 and 2). We demonstrated that the IVT mRNA complexed with 
DosK did not penetrate tissues efficiently (Fig.2B and D). These results were not surprising as we observed 
consistently that protein synthesis correlated positively with the amount of mRNA present in the cell cytoplasm 
and released in time from the endocytic system (Fig. 1 and 3).  
 
     Interestingly, culturing cells on either fibronectin or collagen, two essential components of the ECM 
abundant in muscle tissue, was sufficient to cause a switch in the entry pathway from caveolin to clathrin (Fig. 
4), but not to induce a boost in mRNA release and subsequent protein production, nor to obtain results that 
recapitulate those obtained in vivo. This implied that the entry mechanism alone was not sufficient to explain 
the differences in protein expression observed in vivo. Moreover, the addition of ECM proteins to cultured cells 
was not sufficient to overcome the limits of this in vitro model system.   
 
  Indeed, one of the main limits of experiments performed in vitro using cell lines, is the substrate on which 
cells are cultured (typically glass or plastic), which frequently prohibits the cells from exhibiting the 
physiological properties of functional tissues in vivo. This limitation can be alleviated by the design of 
biomaterials which could recapitulate in vivo mechanobiological properties. For an initial, high-through-put 
screening of nanocarriers in vitro toward the development of vaccine formulations, simple and affordable 
biomaterials exhibiting physiochemical and mechanical properties closely resembling in vivo tissue can be 
utilized.  
 
     Hydrogels have been used for culturing skeletal muscle, myoblast and myotubes. For example, it’s been 
shown that myotubes plated on stiff substrates differentiate into myotubes with very few striations, whereas a 
typical sarcomere banding pattern was observed for myotubes cultured on softer substrates [74]. Tissue 
compliance has also been shown to play an important role in DNA uptake and expression. Multiple studies 
have shown that plasmids transfected into cells plated on a soft substrate express protein more efficiently than 
on a stiffer substrate [53,54,55]. Studies reported earlier showed that hydrogels of Elastic modulus of 10 kPa 
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for myoblast and 12 kPa for myotubes strengthen adhesion, cell spreading and traction force which 
recapitulate the mechanosensitive property of muscle tissue [75,76]. 
 
      Among the various natural or synthetic materials that can be used to assemble hydrogels, polyacrylamide 
(PA) allows for a simple fabrication procedure with well- established protocols to produce statistically compliant 
2D substrates with tunable stiffness. While 3D hydrogels may more accurately model the architecture of some 
tissues and present milieus that lead to more realistic cellular responses, here, 2D hydrogels permitted 
straightforward harvesting of cultured cells for luciferase assays or other downstream procedures. Moreover, 
they represent suitable substrates for high resolution confocal microscopy analysis, which could be performed 
with no alterations of the immunofluorescence protocols to compare the results obtained in vitro and in vivo.      
     
      Consistent with the cited studies, we found that IVT mRNA delivered into muscle cells plated on hydrogels 
of 10 kPa yielded efficient protein production (Fig. 5A), with an overall trend similar to the one observed in vivo. 
Further studies using endosomal entry markers suggested that mRNA entered predominantly via a clathrin 
mediated pathway, and was released efficiently, as soon as 6 h post-delivery (Fig. 5 E-F). Interestingly, clathrin 
and not caveolin mediated endocytosis yielded efficient protein production in this model system, as observed in 
the results obtained in vivo. However, as expected, mRNA uptake per cell on hydrogels was more efficient 
than on glass, which could explain the enhanced protein production obtained on hydrogel (Fig. 6A).  
 
     Overall, our results confirm that the composition and stiffness of the substrate on which cells are cultured 
plays a critical role to characterize various formulations of IVT mRNA complexed with nanocarriers in vitro, to 
successfully predict mRNA expression in vivo. Cellular uptake and expression of nanocomplexes depend on 
their physiochemical properties as well as on the biomechanical properties of cell membranes, including cell 
membrane surface area, membrane tension, bending modulus [77,78], focal adhesion [45,47,52] and elasticity 
[51,59]. All these properties can be modulated by varying the stiffness of the substrate. According to our 
findings, the difference in stiffness of glass and the hydrogels may explain the differences between the results 
obtained in vitro and in vivo, indicating that hydrogels may represent a suitable tool for the initial 
characterization, in vitro, of various IVT mRNA/delivery vehicle complexes. Mechanotransduction is known to 
affects various cellular processes like motility, adhesion, proliferation, migration, apoptosis, and differentiation 
[45,46,47,48]  and to influence the efficiency of plasmid expression [54,55,79]. However, little is known about 
the effects on the regulation of translational mechanisms upon IVT mRNA delivery. The results obtained by 
RNAseq suggest that cells cultured on hydrogel significantly overexpressed genes involved in mRNA 
translation, compared to those cultured on glass, indicating that mechanical forces applied to cells influence 
the activation of mRNA translational pathways. The analysis of data on GSEA confirmed a strong positive 
correlation between enhanced RNA translation pathway and expression of ribosomal genes (Fig. 6B). 
 
5. Conclusion 
 
     Our results demonstrate that IVT mRNA uptake, trafficking, endosomal release and expression in vitro 
using a hydrogel model leads to expression of both naked mRNA or mRNA complexed with CholK and a 
significant decrease in protein production with mRNA complexed to DosK, as observed in vivo. We conclude 
that the differences observed in vitro and in vivo depend on tissue stiffness, which initiates mechanosensitive 
signals resulting in improved uptake of IVT mRNA and upregulation of translation related genes. Thus, these 
study highlights some of the factors responsible for in vivo and in vitro discrepancies and, will assist in the 
characterization of IVT mRNA based vaccines in vitro using tunable hydrogel models. 
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Fig. 1. IVT mRNA expression differs in vitro and in vivo. A) Luciferase mRNA (500 ng) was delivered to 
HSkMSC cells alone or complexed with CholK or DosK. Protein expression is shown in green and nuclei are 
stained with DAPI in blue. Scale bars are 15 µm. Experiment was performed three times in duplicate. B) The 
Luciferase activity was detected by bright glo luciferase assay system and the reads were normalized to 
untransfected controls.* Indicates p < 0.05, tested by one-way ANOVA followed by Holm-Sidak multiple 
comparison testing. Luciferase assay experiments were performed three times in triplicates. C) Mice were 
injected, i.m., with 10 µg dylight 680 labeled mRNA, naked or complexed with CholK or DosK. IHC was 
performed on muscle tissue extracted 16 h post-delivery. Tissue sections (3 to 4) from 4 mice per condition 
were used for IHC staining. Representative bright field images of DAB staining (brown) were obtained from the 
same section with spot software and mRNA (white) was imaged using the Volocity software. Scale bars are 20 
µm. D) Images (3-4) per condition were quantified with Fiji Image J software and average OD plotted.   
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Fig. 2. IVT mRNA entry pathway differs in vitro and in vivo. A) mRNA colocalization with caveolin1 and 
Clathrin in HSkMSC cells transfected with 500 ng of mRNA alone and complexed with CholK or DosK 1.5 h 
post-delivery. Labeled mRNA is shown in red, the endosomal markers caveolin or clathrin in green and nuclei 
are stained with DAPI (blue). Scale bars are 15 µm. The experiment was performed three times in duplicate. B) 
Tissue sections from mice injected with 10µg of labeled-mRNA (red) alone and complexed with CholK or DosK 
in anterior tibialis muscle, i.m. Tissue sections were stained with caveolin and clathrin (green). Nuclei are 
shown in white. Experiments were performed in 4 mice per condition. Images were taken on an Elyra confocal 
microscope with 60Xobjective. Scale bars are 15 µm. Colocalisation of labeled mRNA with caveolin / clathrin in 
vitro (C) and in vivo (D) quantified with mander’s overlap coefficient via Volocity software. Analysis was 
performed on 15 myofibers per condition. Data is presented as mean of Mander’s correlation coefficient (M1) 
with SD. * Indicates p<0.05, tested by two-way ANOVA followed by Holm-Sidak multiple comparison testing. 
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Fig. 3. IVT mRNA release from the endosomal system in vitro and in vivo. HSkMSC cells were transfected 
with 500 ng of mRNA alone or complexed with CholK or DosK and stained with early to late endosomal 
markers (CD63, EEA1 and Rab7) 6 h post-delivery. Mice (n=4) were injected with10 µg of labeled mRNA alone 
or complexed with CholK or DosK. Tissue sections from muscle tissue were extracted 6 h post-delivery and 
were stained with endosomal markers (CD63, Rab5 and Rab7). The mRNA release in in vitro and in vivo 
studies was quantified as the percentage of free (A) and endosome trapped mRNA (B). mRNA colocalization 
with endosomal markers was quantified by the Mander’s overlap coefficient (C). Analysis was performed on 15 
myofibers per condition. The experiment was repeated twice in duplicate. Statistically significant difference was 
tested by two-way ANOVA followed by Holm-Sidak multiple comparison; * Indicates p<0.05. 
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Fig. 4. Effect of ECM on mRNA entry, release and protein production. Colocalization of labeled IVT mRNA 
with A) Caveolin or clathrin or C) endosomal markers CD63, EEA1 and Rab7 quantified with Mander’s overlap 
coefficient. B) mRNA released from late endosomes was quantified by calculating the percentage of free or 
trapped mRNA as described in material and methods. Quantification was performed on 15 myofibers per 
condition. The experiment was repeated twice in duplicate. D) HSkMSC cells were plated on untreated glass 
coverslips or coated with fibronectin and collagen and were transfected with 500 ng of mRNA alone or 
complexed with CholK or DosK. Luciferase activity was measured with the bright glo assay system 24 h post-
delivery and the reads were normalized to untransfected controls. The mean luminescence was plotted as RLU 
per mg protein. * Indicates p < 0.05, tested by two-way ANOVA followed by Holm-Sidak multiple comparison. 
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Fig. 5. Protein expression, mRNA endosomal entry and release in muscle cells plated on hydrogels.   
HSkMSC cells were seeded on 25 mm coverslips or on hydrogels. The next day, cells were transfected with 8 
µg of IVT mRNA alone or complexed with CholK or DosK. A) Luciferase assay performed 24 h post 
transfection using the bright glo luciferase system and the reads were normalized to untransfected controls. B) 
HSkMSC were plated on glass coverslips or hydrogels and were treated with caveolin and clathrin inhibitors 
prior to mRNA transfection. The luciferase assay was performed 24 h post-delivery and the reads were 
normalized to untransfected controls. Statistically significant difference was tested by two-way ANOVA 
followed by Holm-Sidak multiple comparison, * Indicates p<0.05. Colocalization results between fluorescently 
labeled mRNA (red) and C) caveolin or clathrin (green) and D) with late endosomal markers (green). Scale 
bars are 15 µm. E) Quantification of colocalization with the mean Mander’s overlap coefficient between mRNA 
and caveolin or clathrin. F) mRNA release is quantified as the average percentage of free and trapped mRNA. 
Analysis performed on 15 myofibers per condition. The experiment was repeated twice in duplicate. * Indicates 
p<0.05, tested by two-way ANOVA followed by Holm-Sidak multiple comparison. 
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Fig. 6. Factors associated with efficient translation of mRNA on Hydrogels. A) Uptake of IVT mRNA upon 
delivery to cells plated on glass versus hydrogels. HSkMSC cells were plated on glass coverslips or hydrogels 
and were transfected with 8 µg of mRNA alone or complexed with CholK. The mean mRNA fluorescence 
intensity per cell was measured by flow cytometry and analyzed with the Flow Jo software. B) Total RNA was 
isolated from muscle cells seeded on glass coverslips and hydrogels and RNA sequencing was performed on 
cells plated in triplicate. Volcano plot indicating in red the genes that are significantly expressed by cells 
cultured on hydrogels as compared to glass coverslips. 
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Table 1: Translational efficiency of nanocomplexes in vitro and in vivo. 
 
 
 
 
 
 
 
 
 
 
 
 
Nanocomplexes In vitro In vivo  
(Aminoethyl)chitin/ DNA 
[11]  
2.5-fold increase in 
transfection efficiency 
and lower toxicity than 
naked DNA 
NA 
Lipopeptide with optimal 
histidine and lysine  [12] 
High stability and 
efficient transfection 
NA 
DOTAP based cationic 
liposomes [13] 
Efficient Delivery of 
siRNA to lung cells 
NA 
DOTMA based cationic 
liposomes [13] 
Increased cellular 
delivery of siRNA to 
human airway 
epithelial cells and 
mouse neuroblastoma 
cells 
NA 
Ethylphosphocholine 
based lipoplexes [13] 
Low cytotoxity  Highest intrapulmonary delivery for lung cancer therapy 
Cationic lipid 
dioctadecylamido 
glycylspermine 
(Transfectam, DOGS) [14] 
NA High level of transfection in mouse brain 
Cholesterol based 
nanoplexes [15] 
Efficient transfection in 
presence of NaCl 
Efficient transfection in water with respect to naked DNA 
Polyethylenimine, PEI / 
DNA complexes [16] 
Low transfection 
efficiency 
High transfection efficiency 
Pegylated 
DOTAP/Cholesterol – DNA 
complexes [17] 
Inefficient transfection  Improved stability and biodistribution 
Nonionic amphiphile block 
copolymer PE6400/DNA 
complexes[18]  
 
Inefficient transfection High transfection efficiency in skeletal and cardiac muscles 
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Table 2: Sequence of the oligonucleotides targeting the 3’UTR region of the IVT mRNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
RNA target  
 
Sequences 
Homo sapiens albumin (ALB) mRNA (3’ 
UTR), NM_000477.6 
 
GCATCACATTTAAAAGCATCTCAGCCTACCATGAGAATAAGA 
GAAAGAAAATGAAGATCAATAGCTTATTCATCTCTTTTTCTTT 
TTCGTTGGTGTAAAGCCAACACCCTGTCTAAAAAACATAAATT 
TCTTTAATCATTTTGCCTCTTTTCTCTGTGCTTCAATTAATAAA 
AAATGGAAA 
Probe 1   TTTXTTTUAXUCUCAXGGUAGGCXGA 
Probe 2 TTTXTTTGAXGAAUAAGCXAUUGA 
Probe 3 TTTXTTTACAGGGXG UGGCXUUACA 
HBA1 – Homo sapiens hemoglobin subunit 
alpha 1 mRNA (3’ UTR), NM_000558.4 
GCTGGAGCCTCGGTGGCCATGCTTCTTGCCCCTTGGGCC 
TCCCCCCAGCCCCTCCTCCCCTTCCTGCACCCGTACCCCC 
GTGGTCTTTGAATAAAGTCTGAGTGGGCGGCAAAAAAAAA
AA 
Probe 1 TTTTTTTAAGCAUGGCCACCGAGG 
Probe 2 TTTTTTTUCAAAGACCACGGGGG 
Probe 3 TTTTTTTGCCGCCCACUCAGACU 
 Boldface: 2'-O-Methyl RNA; X: dT-C6-NH2; all others are DNA; 
underline: binding region  
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Table 3:  Result of GSEA analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
Four pathways identified by the GSEA method related to mRNA translation are enriched in cells transfected on 
hydrogel. P values are indicated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pathway name P value 
Kegg Ribosome 0 
mRNA Translation 0 
Metabolism of 
mRNA Translation 
0 
3’ UTR  Mediated  
mRNA Translation 
0 
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Table 4: List of genes related to RNA translation pathways. 
GENE SYMBOL GENE_TITLE RANK IN GENE LIST 
RANK METRIC 
SCORE RUNNING ES 
CORE 
ENRICHMENT 
SRP54 
signal 
recognition 
particle 54kDa 
2500 1.01 -0.2915 Yes 
RPL26   ribosomal protein L26 2528 -1.009 -0.2726 Yes 
RPS6 ribosomal protein S6 2570 -1.029 -0.2579 Yes 
RPL27 ribosomal protein L27 2582 -1.034 -0.2327 Yes 
RPL29 ribosomal protein L29 2588 -1.037 -0.2054 Yes 
RPS15A ribosomal protein S15a 2594 -1.041 -0.178 Yes 
RPS9 ribosomal protein S9 2602 -1.044 -0.1511 Yes 
RPS5 ribosomal protein S5 2605 -1.044 -0.1226 Yes 
RPL39 ribosomal protein L39 2788 -1.206 -0.1517 Yes 
RPL34 ribosomal protein L34 2793 -1.214 -0.119 Yes 
EIF3E 
 Translational 
Initiation 
Factor 3 
2799 -1.218 -0.0866 Yes 
RPS29 ribosomal protein S29 2852 -1.349 -0.0668 Yes 
SEC61G Sec61 gamma 
subunit 2886 
-1.544 
 
-0.0349 Yes 
RPS3A ribosomal protein S3A 2902 -1.653 0.0062 Yes 
Genes overexpressed in cells transfected on hydrogels and enriched in the RNA translation and 3’UTR 
mediated RNA translation pathways. 
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Table 5: Summary of experimental results. 
 In vitro In vivo Hydrogel 
Naked 
mRNA 
No protein expression High protein expression Higher protein expression 
than in vitro 
 Caveolin-mediated 
endocytosis 
clathrin-mediated 
endocytosis 
clathrin-mediated 
endocytosis 
 mRNA trapped in 
endosomes 6h post 
delivery 
mRNA released from 
endosomes 6h post 
delivery 
mRNA released from 
endosomes 6h post 
delivery 
    
mRNA+ 
CholK 
No protein expression High protein expression Higher protein expression 
than in vitro 
 Caveolin-mediated 
endocytosis 
clathrin-mediated 
endocytosis 
clathrin-mediated 
endocytosis 
 mRNA trapped in 
endosomes 6h post 
delivery 
mRNA released from 
endosomes 6h post 
delivery 
mRNA released from 
endosomes 6h post 
delivery 
    
mRNA+ 
DosK 
High protein expression No protein expression Lower protein expression 
than in vitro 
 Caveolin-mediated 
endocytosis 
No mRNA entry clathrin-mediated 
endocytosis 
 mRNA released from 
endosomes 6h post 
delivery 
NA 
 
mRNA released from 
endosomes 6h post 
delivery 
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Fig. S1. Schematic of IVT mRNA labeling and FISH. A) Neutravidin (yellow) is conjugated to biotinylated 
fluorescently labeled (green stars) oligonucleotides (black dotted line) to form MTRIPs. Three MTRIPs 
complementary to three sequences within the 3’UTR of the IVT mRNA are utilized for labeling and visualization 
in vivo and in vitro.  B) Dylight 650 pre-labeled mRNA (100 ng) were delivered to A549 cells using Viromer 
RED-based transfection. Six hours after delivery, cells were fixed and FISH was performed using 5nM Quazar 
570 Stellaris RNA probes complementary to the transcript coding region. The colocalization of the MTRIP (red) 
and FISH (green) fluorescent signals is demonstrated by the intensity profile along the white line in the cropped 
image corresponding to the boxed area. C) Cy3b pre-labeled mRNA (10 µg) were delivered to mice via IM 
injection. Two hours after delivery, mice were sacrificed and tissue samples utilized for FISH with 5 nM Quazar 
670 Stellaris RNA probes complementary to the transcript coding region. The colocalization of the MTRIP (red) 
and FISH (green) fluorescent signals is demonstrated by the intensity profile along the white line in the cropped 
image corresponding to the boxed area. No fluorescence signal is observed in mock transfected cells (sham 
delivery). 
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Fig. S2. Characterization of IVT mRNA labeling. A) Luciferase expression in HeLa cells was measured in 
cells transfected with Lipofectamine 2000 with 300ng of unlabeled or Cy3 labeled mRNA. Labeled mRNA is 
shown in red, luciferase protein expression in green and nuclei stained with DAPI in blue. The scale bars are 
15 µm. B) Quantification was performed on 30 cells and mean fluorescence intensity was plotted. The 
experiment was repeated twice in duplicate. 
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Fig. S3. IVT mRNA endosomal release in vitro and in vivo.  A) HSkMSC cells were transfected with 500 ng 
of mRNA alone or complexed with CholK or DosK and stained with early to late endosomal markers (CD63, 
EEA1 and Rab7) 6h post delivery. The labeled RNA is shown in red, endosomal markers in green and nuclei in 
blue. The experiment was performed three times in duplicate. B) Mice (n=4) were injected with10 µg of labeled 
mRNA alone or complexed with CholK or DosK. Tissue sections from muscle tissue were extracted 6 h post 
delivery and were stained with endosomal markers (CD63, Rab5 and Rab7). Representative images show 
mRNA in red, endosomal markers in green and nuclei in white. Scale bars are 15 µm.  
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Fig. S4. Immunofluorescence for Late endosomal markers in vitro. HSkMSC cells were transfected with 
500 ng of IVT mRNA alone or complexed with CholK or DosK and stained with early to late endosomal 
markers (CD63, EEA1 and Rab7) 1.5h post-delivery. Labeled mRNA is shown in red, endosomal markers in 
green and nuclei in blue. Scale bars are 15 µm.  Experiment was performed independently twice in duplicate. 
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Fig. S5. Immunofluorescence for endosomal markers in vivo. Mice (n=4) were injected with 10 µg of 
labeled IVT mRNA alone or complexed with CholK or DosK. Tissue sections from muscle tissue were 
extracted 1.5h post delivery and were stained with endosomal markers (CD63, Rab5 and Rab7). 
Representative images show mRNA in red, endosomal markers in green and nuclei in blue. Scale bars are 15 
µm.  
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Fig. S6. Effect of ECM proteins on IVT mRNA endocytic pathway. HSkMSC cells were grown on Labtek II 
plates coated with fibronectin and collagen (100 µM) and were transfected with 500 ng of cy3b labeled mRNA 
(red) alone or complexed with CholK or DosK. Cells were stained with endosomal entry markers caveolin1 and 
clathrin (green) 1.5h post delivery. The experiment was performed thrice in duplicate. 
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Fig. S7. Effect of ECM proteins on IVT mRNA endosomal release. Cells were stained with mid to late 
endosomal markers, CD63, EEA1 and Rab7, 6h post delivery. Labeled mRNA is shown in red, endosomal 
entry markers or mid to late endosomal markers in green and nuclei in blue. Scale bars are 15 µm. Experiment 
was performed three times in duplicate.  
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Fig. S8. IVT mRNA entry pathway and protein expression in differentiated myotubes. A) mRNA 
colocalization with caveolin1 and clathrin in myotubes transfected with 500 ng of mRNA alone and complexed 
with CholK or DosK 1.5h post-delivery. Labeled mRNA is shown in red, the endosomal markers caveolin or 
clathrin in green and nuclei are stained with DAPI (blue). Scale bars are 15 µm. The experiment was 
performed twice in duplicate. B) Colocalization of labeled mRNA with caveolin / clathrin in vitro was quantified 
with mander’s overlap coefficient via Volocity software. Analysis was performed on 20 myofibers per condition. 
Data is presented as mean of Mander’s correlation coefficient (M1) with SD. * Indicates p<0.05, tested by two-
way ANOVA followed by Holm-Sidak multiple comparison testing. C) The Luciferase activity was detected by 
bright glo luciferase assay system and the reads were normalized to untransfected controls. * Indicates 
p<0.05, tested by one-way ANOVA followed by Holm-Sidak multiple comparison testing. The experiment was 
performed twice in triplicate. 
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Fig. S9. IVT mRNA entry pathway and protein expression of IVT mRNA in Sol8. A) mRNA colocalization 
with caveolin1 and clathrin in mouse muscle cells transfected with 500 ng of mRNA alone and complexed with 
CholK or DosK 1.5h post-delivery. Labeled mRNA is shown in red, the endosomal markers caveolin or clathrin 
in green and nuclei are stained with DAPI (blue). Scale bars are 15 µm. The experiment was repeated once in 
duplicate. B) Colocalization of labeled mRNA with caveolin / clathrin in vitro was quantified with mander’s 
overlap coefficient via Volocity software. Analysis was performed on 20 cells per condition. Data is presented 
as mean of Mander’s correlation coefficient (M1) with SD. * Indicates p<0.05, tested by two-way ANOVA 
followed by Holm-Sidak multiple comparison testing. C) The Luciferase activity was detected by bright glo 
luciferase assay system and the reads were normalized to untransfected controls. * Indicates p<0.05, tested by 
one-way ANOVA followed by Holm-Sidak multiple comparison testing. The luciferase assay was performed 
twice in triplicate. 
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Fig. 10. Protein expression on human skeletal muscle cell line plated on varying substrate stiffness. 
HSkMSC cells were seeded on 25 mm coverslips or on hydrogels of varying stiffness (1, 10 and 100 kPa) as 
well as on glass. The next day, cells were transfected with 8 µg of mRNA complexed with CholK. Luciferase 
assay was performed 24 h post transfection using the bright glo luciferase system and the reads were 
normalized to untransfected controls. * Indicates p<0.05, tested by one-way ANOVA followed by Holm-Sidak 
multiple comparison testing. The luciferase assay was performed twice in triplicate. 
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